BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 24570371)

  • 1. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
    Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
    mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host.
    Bahadori M; Motamedifar M; Derakhshandeh A; Firouzi R; Motamedi Boroojeni A; Alinejad M; Naziri Z
    Microbiologyopen; 2019 Jun; 8(6):e00759. PubMed ID: 30358940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.
    Toval F; Köhler CD; Vogel U; Wagenlehner F; Mellmann A; Fruth A; Schmidt MA; Karch H; Bielaszewska M; Dobrindt U
    J Clin Microbiol; 2014 Feb; 52(2):407-18. PubMed ID: 24478469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community.
    Matsui Y; Hu Y; Rubin J; de Assis RS; Suh J; Riley LW
    Microbiologyopen; 2020 Jun; 9(6):1225-1233. PubMed ID: 32189451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
    Rezatofighi SE; Mirzarazi M; Salehi M
    BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli ST131-
    Liu CM; Stegger M; Aziz M; Johnson TJ; Waits K; Nordstrom L; Gauld L; Weaver B; Rolland D; Statham S; Horwinski J; Sariya S; Davis GS; Sokurenko E; Keim P; Johnson JR; Price LB
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154256
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotypic analysis of uropathogenic Escherichia coli to understand factors that impact the prevalence of β-lactam-resistant urinary tract infections in a community.
    Tarlton NJ; Moritz C; Adams-Sapper S; Riley LW
    J Glob Antimicrob Resist; 2019 Dec; 19():173-180. PubMed ID: 30872040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.
    Nielsen KL; Stegger M; Kiil K; Godfrey PA; Feldgarden M; Lilje B; Andersen PS; Frimodt-Møller N
    Int J Med Microbiol; 2017 Dec; 307(8):497-507. PubMed ID: 29031453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli.
    Er DK; Dundar D; Uzuner H; Osmani A
    Microb Pathog; 2015 Dec; 89():188-94. PubMed ID: 26518125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
    Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
    Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli clonal group A causing bacteraemia of urinary tract origin.
    Skjøt-Rasmussen L; Olsen SS; Jakobsen L; Ejrnaes K; Scheutz F; Lundgren B; Frimodt-Møller N; Hammerum AM
    Clin Microbiol Infect; 2013 Jul; 19(7):656-61. PubMed ID: 22784317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil.
    Dias RC; Marangoni DV; Smith SP; Alves EM; Pellegrino FL; Riley LW; Moreira BM
    Microb Drug Resist; 2009 Dec; 15(4):303-8. PubMed ID: 19857137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
    Totsika M; Kostakioti M; Hannan TJ; Upton M; Beatson SA; Janetka JW; Hultgren SJ; Schembri MA
    J Infect Dis; 2013 Sep; 208(6):921-8. PubMed ID: 23737602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel chaperone-effector-immunity system identified in uropathogenic
    Casiano González A; Pacheco Villanueva A; Castro-Alarcón N; Méndez J; Oropeza R; Martínez-Santos VI
    PeerJ; 2024; 12():e17336. PubMed ID: 38784397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ColiSeq: a multiplex amplicon assay that provides strain level resolution of
    Williamson CHD; Vazquez AJ; Nunnally AE; Kyger K; Fofanov VY; Furstenau TN; Hornstra HM; Terriquez J; Keim P; Sahl JW
    Microbiol Spectr; 2024 Jun; 12(6):e0413923. PubMed ID: 38651881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.